Search

Catalogue Name :
HuSu-TRANS-MSC
Cell Type/ Tissue:
Mesenchymal Stem Cells
Species:
Human
Cell & Tissue Source:
Stroma
Donor (health) Status:
Normal/ Healthy
Purity:
≥ 92 %

Available Options

  • Unit #1:  2*106 frozen Cells

In Stock

$475.00

Human adult tissue processed primary progenitor surrogate in vitro platform to read relevant transcriptomics, cytokine involved inflammatory pathways, Pulmonotoxicity, tumorogenicity etc
Human Vaccine Candidates Discovery and Development on Non-Animal Systems
An adoption with meaningful repercussions
The principles of Humane Experimental Technique has resulted in Rs concept Replacement Reduction and Refinement of animal tests The number of animals used for both preclinical and quality control is thought to be reduced to zero if vaccines are better characterised while allowing testings by a set of in vitro methods rather than in vivo scenarios The in vitro methods to detect safety related to potency of vaccines can employ alternative platforms like that of human derived celltissue based surrogate systems The humane technique facilitating increased control of critical stepsin production relating safety with potency international harmonisation and validation of test procedures
human-vaccine-candidates-discovery

Please contact your local sales representative or Transcell support at support@transcell.com for further information.

Available Resources

Catalogue Name :
HuSu-TRANS-MSC
Cell Type/ Tissue:
Mesenchymal Stem Cells
Species:
Human
Cell and Tissue Source:
Bone marrow, adipose tissue, dental pulp, placenta, or umbilical cord
Donor (health) Status:
Normal/ Healthy
Ethnicity:
Indian/ South Asian
Purity:
≥ 92 %

Reviews

There are no reviews yet.

Write a review

Back to Top
Product has been added to your cart